¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ȯ"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 8 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • gastropathy
    À§º´Áõ, À§Áúȯ
  • gastrosia
    À§Áúȯ
  • gastrosia fungosa
    Áø±ÕÀ§º´, °õÆÎÀÌÀ§Áúȯ
  • gene conversion
    À¯ÀüÀÚÀüȯ
  • gene replacement
    À¯ÀüÀÚ±³È¯
  • genetic disorder
    À¯ÀüÁúȯ
  • geographical pathology
    Áö¸®º´¸®ÇÐ, ±âÈÄȯ°æº´¸®ÇÐ
  • geomedicine
    ±âÈÄȯ°æÀÇÇÐ, Áö¸®ÀÇÇÐ
  • geopathology
    ±âÈÄȯ°æº´¸®ÇÐ, Áö¸®º´¸®ÇÐ
  • gerontoxon
    ³ë³âȯ
  • globulus
    1. ȯ¾à 2. °ø, ±¸Ã¼ 3. µ¢¾î¸®
  • glomerular disease
    Å丮º´, »ç±¸Ã¼Áúȯ
  • gustatory hallucination
    ¹Ì°¢È¯°¢, ȯ¹Ì
  • gas exchange ratio
    °¡½º±³È¯ºñÀ²
  • hyperkinemia
    ¼øÈ¯Ç÷·ù·®°ú´Ù
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • intercurrent disease
    º´¹ßÁúȯ
  • intestinal motility disorder
    âÀڿÀå¾Ö, Àå¿îµ¿Áúȯ
  • ischemic heart disease
    ÇãÇ÷½ÉÀåÁúȯ, ÇãÇ÷½ÉÀ庴
  • liver disease
    °£º´, °£Áúȯ
  • lymphoproliferative disorder
    ¸²ÇÁ¼¼Æ÷Áõ½ÄÁúȯ
  • malabsorptive disorder
    Èí¼öÀå¾ÖÁúȯ
  • mendelian disorder
    ¸àµ¨À¯ÀüÁúȯ
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • multifactorial genetic disorder
    ´ÙÀμºÀ¯ÀüÀå¾Ö, ´ÙÀμºÀ¯ÀüÁúȯ
  • myelodysplastic disorder
    °ñ¼öÇü¼ºÀÌ»óÁúȯ
  • myeloproliferative disorder
    °ñ¼öÁõ½ÄÁúȯ
  • neurological disorder
    ½Å°æ°èÀå¾Ö, ½Å°æ°èÁúȯ
  • neuromuscular disorder
    ½Å°æ±ÙÀ°Àå¾Ö, ½Å°æ±ÙÀ°Áúȯ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üÁúȯ
  • oneiric delirium
    ¸ùȯ¼¶¸Á
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • glutathione reductase deficiency
    ±Û·çŸƼ¿Â ȯ¿øÈ¿¼Ò °áÇÌÁõ.
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • glyoxylate reductase
    ±Û¸®¿Á½Ç»êȯ¿øÈ¿¼Ò.
  • gold foil annealing tray
    ±Ý¹Ú¼Òȯ±â(ÐÝÚØáÀü½Ðï).
  • gonococcal epididymitis
    ÀÓ±Õ¼º ºÎ°íȯ¿°.
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ
  • granulomatous disease of childhood
    ¼Ò¾ÆÀ°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease of childhood
    ¼Ò¾Æ À°¾ÆÁ¾¼º Áúȯ
  • grater circulation
    ´ë¼øÈ¯.
  • greater circulation
    ´ë¼øÈ¯(ÓÞâàü»).
  • gubernacular canal
    °íȯµµ´ë°ü(°íȯµµ´ë°ü).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • case finding
    ȯÀÚ¹ß°ß (ü´íºÛ¡úæ), Áõ·Ê¹ß°ß.
  • case finding program
    ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷.
  • air ambulance
    ȯÀÚ¼ö¼ÛºñÇà±â.
  • sickroel behavior
    ȯÀÚ¿ªÇÒÇàÅÂ.
  • stretcher
    ȯÀÚ¿î¹ÝÂ÷.[Á¤Çü]µé°Í, ½ÅÀå±â.
  • patient positioning
    ȯÀÚÀ§Ä¡°áÁ¤
  • patient triggered respirator
    ȯÀÚÀ¯¹ß½ÄÀΰøÈ£Èí±â.
  • patient triggered ventilator
    ȯÀÚÀ¯¹ßÈ£Èí±â(ü´íºë¯Û¡û¼ýåÐï).
  • informed consent
    ȯÀÚÀÇ µ¿ÀÇ, ½Â³«
  • patient position
    ȯÀÚÀÇ ÀÚ¼¼
  • complaints of patient
    ȯÀÚÀÇ È£¼Ò(ü´íº¡­û¼áÍ).
  • patient preparation
    ȯÀÚÁغñ
  • patient evaluation
    ȯÀÚÆò°¡
  • patient identification
    ȯÀÚÈ®ÀÎ
  • patient performance index
    ȯÀÚȰµ¿°è¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • biliary cycle
    ´ãÁó ¼øÈ¯(¡­¼øÈ¯).
  • biliary cycle
    ´ãÁó ¼øÈ¯(¡­âàü»)
  • biliary tract disease
    ´ãµµÁúȯ
  • bioreductive agent
    »ýüȯ¿ø¹°Áú
  • bioreductive drug
    »ýüȯ¿ø¼º¾àÁ¦, -¾à¹°
  • biosphere
    ´ë»ýȰ±Ç, »ý¹°È¯°æ¹ÝÀÀ±Ç, »ý¹°±Ç(ßæÚªÏê).
  • biosphere
    ´ë»ýȰ±Ç, »ý¹°È¯°æ¹ÝÀÀ±Ç, »ý¹°±Ç(Ë×ËÑË´).
  • biotransformation
    »ýüº¯È­<º¯È¯>(¡­Ü¨ûù<ܨüµ>).
  • biotransformation
    »ýü³»º¯È­<º¯È¯>(¡­Ò®Ü¨ûù<ܨüµ>)
  • biotransformation
    »ýü³»º¯È¯.
  • bissa
    ºñ½Î ¡ìÀÌÁýÆ® ºÎÁ¾¼º Áúȯ¡í.
  • bladder replacement
    ¹æ±¤Ä¡È¯(¼ú)
  • blistering(bullous) disease
    ¼öÆ÷¼ºÁúȯ(¡­òðü´)
  • blood circulation
    Ç÷¾×¼øÈ¯(úìäûâàü»).
  • blood disease
    Ç÷¾×Áúȯ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • C62.1
    Descended testis
    Çϰ­ °íȯ
  • C62.9
    Testis, unspecified
    »ó¼¼ºÒ¸íÀÇ °íȯ
  • C63.0
    Epididymis
    ºÎ°íȯ
  • C88
    Malignant immunoproliferative diseases
    ¾Ç¼º ¸é¿ªÁõ½Ä¼º Áúȯ
  • C88.7
    Other malignant immunoproliferative diseases
    ±âŸ ¾Ç¼º ¸é¿ªÁõ½Ä¼º Áúȯ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • malum
    Áúȯ, Áúº´
  • manual reposition
    ¿ë¼ö ȯ³³¹ý, ¿ë¼ö Á¤º¹
  • margo anterior testis
    °íȯ Àü¿¬
    Á¤¼ÒÀÇ µÕ±Ù ÀÚÀ¯ ¿¬.
  • massa lateralis atlantis
    ȯÃß ¿ÜÃø ±«
    ȯÃß°ñ ¿ÜÃø µ¢ÀÌ.
  • matrix band
    °Ýº® ¹êµå, ȯ»ó °Ýº®
    1. 2±Þ ¿Íµ¿ ÃæÀü ½Ã »ó½ÇµÈ ÀÎÁ¢ ¸é¸¦ ´ë½ÅÇϱâ À§ÇØ ÃæÀü¹° ÃæÀü¿¡ »ç¿ëÇÏ´Â ¹êµå. 2. ¿Íµ¿ Áß¿¡ ¾Æ¸»°¨À» ÃæºÐÈ÷ Àü»öÇϱâ À§ÇÏ¿©, ¶Ç´Â º¹À⠿͵¿ÀÇ °á¼Õ º®À» ä¿ì±â À§ÇÏ¿© Ä¡¾Æ µÑ·¹¿¡ ºÙÀÎ ¾ãÀº ±Ý¼Ó Æí.
  • medical ICU
    ³»°ú°è ÁßȯÀÚ½Ç
  • melancholiac
    ¿ïº´ ȯÀÚ, ¿ì¿ïÁú
  • membrana atlanto-occipitalis posterior
    ÈÄȯÃß Èĵθ·, µÚ°í¸® µÚÅë¼ö ¸·, µÚȯÃß Èĵθ·
    ȯÃßÀÇ Èıÿ¡¼­ ÀüµÎ°ñÀÇ ÈĹæ°è¸¦ Áö³ª°í, À§Ä¡ÀûÀ¸·Î Ȳ»ö Àδ뿡 ´ëÀÀÇÏ´Â ´ÜÀÏÀÇ Á¤Áߺο¡ ÀÖ´Â ÀÎ´ë ±¸Á¶.
  • micro-orchidism
    ¼Ò°íȯÁõ
    °íȯÀÌ ºñÁ¤»óÀûÀ¸·Î ÀÛÀº °Í.
  • microrchidia
    ¼Ò°íȯÁõ
    °íȯÀÌ Á¤»ó ÀÌÇÏ·Î ÀÛÀº °Í.
  • milieu
    ȯ°æ
  • mini annular phased array
    ¼Ò ȯ»ó À§»ó ¹è¿­
  • modulation
    º¯Á¶, Á¶Á¤, Á¶Àý, ȯ°æ ÀûÀÀ´É, ÀüÇü
    ȯ°æ¿¡ ´ëÇÑ ¼¼Æ÷ ÀûÀÀ¼ºÀÇ Á¤»ó ´É·Â.
  • monocyclic
    ´ÜȯÀÇ
  • monorchidism
    ´Ü °íȯ, ´Ü °íȯÁõ
    µ¿ÀǾî=monorchism.
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
Æä·ÎÁ¬ÁÖ - »õâ
ȯÀÎÁ¦¾à
A09703941 Sodium ferric gluconate complex
Àü¹®ÀǾàǰ | »èÁ¦
¸ÞŸµ¥ÀÌÆ®CD¼­¹æÄ¸½¶ - »õâ
ȯÀÎÁ¦¾à
G02500021 Methylphenidate HCl
Àü¹®ÀǾàǰ | ±Þ¿©
½É¹Ù½º·ÎÅØ - »õâ
ȯÀÎÁ¦¾à
A09703971 Simvastatin
Àü¹®ÀǾàǰ | ±Þ¿©
Æç¸®½ºÄ¸½¶ - »õâ
ȯÀÎÁ¦¾à
A09703901 »óȲ±Õ»çü¿¢½º
Àü¹®ÀǾàǰ | ±Þ¿©
¹Ù·ùÁ¦ÆÊÁÖ - »õâ
ȯÀÎÁ¦¾à
G01000231 Nalbuphine HCl
Àü¹®ÀǾàǰ | »èÁ¦
¸®Æä¸®µ·Á¤0.5mg - »õâ
ȯÀÎÁ¦¾à
A09704001 Risperidone
Àü¹®ÀǾàǰ | ±Þ¿©
´º·¾Åçĸ½¶300mg - »õâ
ȯÀÎÁ¦¾à
A09703981 Gabapentin
Àü¹®ÀǾàǰ | ±Þ¿©
À¯¶õŹÁ¤75mg - »õâ
ȯÀÎÁ¦¾à
A09751051 Ranitidine HCl
Àü¹®ÀǾàǰ | ±Þ¿©
´ÙÀÌÇǸ±Á¤2mg - »õâ
ȯÀÎÁ¦¾à
A09703991 Glimepiride
Àü¹®ÀǾàǰ | ±Þ¿©
´º·¾Åçĸ½¶100mg - »õâ
ȯÀÎÁ¦¾à
A09704041 Gabapentin
Àü¹®ÀǾàǰ | ±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • bath chair
    (ȯÀÚ ¿ÜÃâ¿ëÀÇ)¹ÙÄû ´Þ¸° ÀÇÀÚ
  • beamy
    (Ç×ÇØ)ÆøÀÌ ³ÐÀº;±¤¼±À» ¹æ»çÇÏ´Â;ºû³ª´Â;ȯÇÑ;Áñ°Å¿î;(¼ö»ç½¿ÀÌ)°¡Áö»ÔÀÌ ÀÖ´Â
  • bedpan
    º¯±â;ȯÀÚ¿ë º¯±â
  • beguilement
    ±â¸¸;¼ÓÀÓ;±âºÐÀüȯ °Å¸®;½É½ÉÇ®À̰¡ µÇ´Â °Í
  • beguiling
    ¼ÓÀÌ´Â;±âºÐÀ» Àüȯ½ÃŰ´Â
  • belt highway
    ¼øÈ¯µµ·Î
  • belt line
    ¼øÈ¯¼±
  • beltway
    ¼øÈ¯µµ·Î
  • bill
    °è»ê¼­;¸ñ·Ï;ȯ¾îÀ½;ÀǾÈ-±¤°íÇÏ´Ù;¿¹°íÇÏ´Ù;û±¸¼­¸¦ º¸³»´Ù;ºÎ¸®;ºÎ¸®¸¦ ¸Â´ë´Ù
  • bioenvironmental
    »ý¹° ȯ°æÀÇ(»ý¹°ÀÇ È¯°æ°ú ƯÈ÷ ±× ¼ÓÀÇ À¯ÇØ ¿ä¼Ò¿¡ °üÇÑ)
  • biohazard
    »ý¹°ÇÐÀû À§Çè(»ç¶÷°ú ±× ȯ°æ¿¡ ´ëÇØ À§ÇèÀÌ µÇ´Â »ý¹°ÇÐÀû ¹°Áú »óȲ)
  • biometeorology
    »ý¹° ȯ°æÇÐ
  • biotron
    ¹ÙÀÌ¿ÀÆ®·Ð(ȯ°æÁ¶°ÇÀ» ÀÎÀ§ÀûÀ¸·Î Á¦¾îÇÏ¿©,±× ¼Ó¿¡¼­ »ý¹°À» ±â¸£´Â ÀåÄ¡)
  • blase
    ȯ¶ô¿¡ ÁöÄ£
  • bleed
    ÃâÇ÷ÇÏ´Ù;ÇÇÈ긮´Ù;½½ÆÛÇÏ´Ù-(ȯÀÚÀÇ)ÇǸ¦ »Ì´Ù;µ·À» ¿ì·Á³»´Ù-ÂïÈù ºÎºÐ±îÁöµµ ÀÚ¸¥»çÁø;ÀμâµÈ ºÎºÐ±îÁöµµ ÀÚ¸¥ »çÁø
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á